← Eichor
Condition: Frontotemporal Lobar Degeneration Ftld Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Frontotemporal Lobar Degeneration Ftld

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Repetitive Transcranial Magnetic Stimulation in Frontotemporal Lobar Degeneration
NA · 1 location(s) · Università degli Studi di Brescia · NCT07316413GENetic Fronto Temporal Dementia Initiative in Lille
NA · 1 location(s) · University Hospital, Lille · NCT04639622Genetic Frontotemporal Dementia Initiative for Neurodevelopment
Phase N/A · 1 location(s) · Western University · NCT05779813Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia
Phase 2 · 3 location(s) · Johns Hopkins University · NCT05386394AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)
Phase 1 · 5 location(s) · Institute for Molecular Medicine · NCT07158905Incremental Diagnostic Value of Tau-PET With [18F]RO948 vs Amyloid-PET in Patients With Cognitive Impairment
NA · 2 location(s) · University Hospital, Geneva · NCT06618872Speech and Language Interventions for Italian People With PPA
Phase N/A · 2 location(s) · Istituti Clinici Scientifici Maugeri SpA · NCT06739967First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia
Phase 1/Phase 2 · 1 location(s) · David Wilson · NCT05374278Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Phase N/A · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT03225144Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A
EARLY_Phase 1 · 2 location(s) · University of Pennsylvania · NCT06932809A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
Phase 1 · 10 location(s) · Eli Lilly and Company · NCT06297590A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Fro
Phase 1/Phase 2 · 19 location(s) · AviadoBio Ltd · NCT06064890Single-centre Descriptive Study of Taste in Frontotemporal Lobar Degeneration Through the Analysis of Taste Evoked Poten
NA · 1 location(s) · Centre Hospitalier Universitaire Dijon · NCT07110207Semantic Rehabilitation for Patients With Primary Progressive Semantic Aphasia
NA · 1 location(s) · University Hospital, Toulouse · NCT04957537Proteinopathies Expression in Skin of Neurodegenerative Disorders
Phase N/A · 1 location(s) · Universidad Autonoma de San Luis Potosí · NCT06528964ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Phase N/A · 27 location(s) · Mayo Clinic · NCT04363684Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases
NA · 1 location(s) · Kuopio University Hospital · NCT05326750Long Term Effect of Brain Stimulation in PPA
NA · 1 location(s) · Hospital San Carlos, Madrid · NCT07158216Longitudinal Early-onset Alzheimer's Disease Study Protocol
Phase N/A · 23 location(s) · Indiana University · NCT03507257Language in Primary Progressive Aphasia
Phase N/A · 1 location(s) · Northwestern University · NCT00537004A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults With Insomnia.
Phase 2 · 1 location(s) · Woolcock Institute of Medical Research · NCT06823752Investigating Genetic Status in Patients Presenting to Clinic
Phase N/A · 1 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT05911932Retinal Imaging in Neurodegenerative Disease
Phase N/A · 1 location(s) · Duke University · NCT03233646PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620
Phase 3 · 1 location(s) · University of Pennsylvania · NCT05456503Links Between Self-awareness and Sociocognitive Processes in Neurodegenerative Diseases
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07531732Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
Phase N/A · 1 location(s) · University Hospital, Lille · NCT05288842Communication Bridge 3 Study
Phase 2 · 1 location(s) · University of Chicago · NCT06191198The Swedish BioFINDER 2 Study
NA · 2 location(s) · Skane University Hospital · NCT03174938Modifiable Variables in Parkinsonism (MVP)
Phase N/A · 1 location(s) · Bastyr University · NCT02194816A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
Phase 3 · 24 location(s) · Novartis Pharmaceuticals · NCT07498426
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.